Comparison of Febuxostat and Allopurinol in the Treatment of Patients with Chronic Kidney Disease Stage 3∼5 with Hyperuricemia

Comparison of Febuxostat and Allopurinol in the Treatment of Patients with Chronic Kidney Disease Stage 3∼5 with Hyperuricemia

Objective. To compare the efficacy of febuxostat and allopurinol in the treatment of chronic kidney disease (CKD) at stages 3∼5 with hyperuricemia. Methods. A total of 100 patients with stage 3 to 5 CKD with hyperuricemia in our hospital from July 2018 to December 2019 were selected and divided into...

Full description

Saved in:

Bibliographic Details
Main Authors:	Zhimin Liao, Lei Xu, Bo Wan, Liping Wang, Chengzhi Zhao, Gang Wu, Rui Xie
Format:	Article
Language:	English
Published:	Wiley 2022-01-01
Series:	Emergency Medicine International
Online Access:	http://dx.doi.org/10.1155/2022/1177946
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Febuxostat Improves Uric Acid Levels and Renal Function in Patients with Chronic Kidney Disease and Hyperuricemia: A Meta-Analysis
by: Yanqun Zheng, et al.
Published: (2022-01-01)

Asymptomatic Hyperuricemia and the Kidney: Lessons from the URRAH Study
by: Cecilia Barnini, et al.
Published: (2025-01-01)

Performance of Ultrasound in the Clinical Evaluation of Gout and Hyperuricemia
by: Ling Cao, et al.
Published: (2021-01-01)

Febuxostat Attenuates Renal Damage besides Exerting Hypouricemic Effect in Streptozotocin-Induced Diabetic Rats
by: Jianmin Ran, et al.
Published: (2017-01-01)

A Brief Review of Analytical Methods for the Estimation of Allopurinol in Pharmaceutical Formulation and Biological Matrices
by: Hemraj Sharma, et al.
Published: (2021-01-01)

Management of intraocular pressure and inflammation using febuxostat film: in vitro - in vivo correlation
by: Mouli Das, et al.
Published: (2025-01-01)

Design and Optimization of Colorimetric Paper-Based Analytical Device for Rapid Detection of Allopurinol in Herbal Medicine
by: Rimadani Pratiwi, et al.
Published: (2019-01-01)

Comparison between the HLA-B∗58 : 01 Allele and Single-Nucleotide Polymorphisms in Chromosome 6 for Prediction of Allopurinol-Induced Severe Cutaneous Adverse Reactions
by: Niwat Saksit, et al.
Published: (2017-01-01)

Febuxostat and Increased Dialysis as a Treatment for Severe Tophaceous Gout in a Hemodialysis Patient
by: Lynda Ann Frassetto, et al.
Published: (2016-01-01)

A Mendelian randomization study: physical activities and chronic kidney disease
by: Rui Xiao, et al.
Published: (2024-12-01)

New Urea and Thiourea Derivatives of Piperazine Doped with Febuxostat: Synthesis and Evaluation of Anti-TMV and Antimicrobial Activities
by: Reddivari Chenna Krishna Reddy, et al.
Published: (2013-01-01)

A Rare Case of Multiorgan Calciphylaxis in a Patient with Stage 5 Chronic Kidney Disease
by: Abdulrahman Ahmad, et al.
Published: (2018-01-01)

The role of probiotics in ameliorating hyperuricemia: a review
by: ZOU Yan, HUANG Enshan, ZHAO Dong, HUANG Lichun, SU Danting, ZHANG Ronghua
Published: (2025-01-01)

Hyperuricemia: An Early Marker for Severity of Illness in Sepsis
by: Sana R. Akbar, et al.
Published: (2015-01-01)

Relationship of Blood Groups to the Incidence of Hyperuricemia and Hyperglycemia
by: Abbas Mehsen Gata, et al.
Published: (2021-12-01)

The efficacy of a low-dose combination of febuxostat and benzbromarone versus each drug used alone for the treatment of gout
by: Caiyu Zheng, et al.
Published: (2025-02-01)

Association of alcohol abstinence with risk of hyperuricemia in rural Chinese adults: the Henan Rural Cohort Study
by: Xiaokang Dong, et al.
Published: (2025-02-01)

Associations of dietary choline intake and kidney function with hyperuricemia in Chinese children and adolescents: a cross-sectional studyResearch in context
by: Chengping Li, et al.
Published: (2025-01-01)

The Polymorphism rs2725220 Is Associated with Hyperuricemia in the Korean Population
by: Jae Woong Sull, et al.
Published: (2014-12-01)

Aquaporin-2 in the early stages of the adenine-induced chronic kidney disease model.
by: Lucas H Oronel, et al.
Published: (2025-01-01)

Hyperuricemia-induced complications: dysfunctional macrophages serve as a potential bridge
by: Wenyi Gu, et al.
Published: (2025-01-01)

Sacubitril/Valsartan for Blood Pressure Lowering in Non‐Dialysis‐Dependent Chronic Kidney Disease Stage 3–5 Patients With Hypertension: A Multicenter Clinical Study
by: Yu Yan, et al.
Published: (2025-01-01)

Trimethylamine N-Oxide (TMAO) Plasma Levels in Patients with Different Stages of Chronic Kidney Disease
by: Marcia Ribeiro, et al.
Published: (2024-12-01)

Anesthesia in Parathyroidectomy for Secondary Hyperparathyroidism of Chronic Kidney Disease
by: ZHANG Yangyang, et al.
Published: (2024-11-01)

The association between body roundness index and new-onset hyperuricemia in Chinese population: the Kailuan cohort study
by: Xi Cai, et al.
Published: (2025-01-01)

Effects of bioactive peptides combined with probiotics on serum uric acid in patients with hyperuricemia
by: HAN Dan，ZHAO Ya，HUANG Enshan，YE Shuhua，WANG Wanjin，WU Fangmin，WANG Dingliang，ZHANG Ronghua
Published: (2025-01-01)

Ameliorative effect of Lacticaseibacillus rhamnosus Fmb14 from Chinese yogurt on hyperuricemia
by: Hongyuan Zhao, et al.
Published: (2023-07-01)

Hyperuricemia Increases the Risk of Atrial Fibrillation: A Systematic Review and Meta-Analysis
by: Zheng Gao, et al.
Published: (2022-01-01)

First Report on Association of Hyperuricemia with Type 2 Diabetes in a Vietnamese Population
by: Tran Quang Binh, et al.
Published: (2019-01-01)

Hyperuricemia prevalence and its risk factors in uremic patients undergoing maintenance hemodialysis
by: Meng Zhang, et al.
Published: (2025-01-01)

Increased serum soluble PD-l1 levels in patients with advanced stages of chronic kidney disease
by: Ayaka Hayashi, et al.
Published: (2025-01-01)

Charge transfer interaction of organic p-acceptors with the anti-hyperuricemic drug allopurinol: Insights from IR, Raman, 1H NMR and 13C NMR spectroscopies
by: Refat Moamen S., et al.
Published: (2016-12-01)

Serum hydroxycotinine was associated with chronic kidney disease (CKD): a cross-sectional study based on NHANES
by: Meng’en Zhu, et al.
Published: (2024-12-01)

Skin autofluorescence as part of the comprehensive assessment of clinical and metabolic status of patients with end-stage chronic kidney disease
by: Darya Yu. Konovalova, et al.
Published: (2024-12-01)

Effect of Different Stages of Chronic Kidney Disease and Renal Replacement Therapies on Oxidant-Antioxidant Balance in Uremic Patients
by: Hadja Fatima Tbahriti, et al.
Published: (2013-01-01)

The link between hyperuricemia and diabetes: insights from a quantitative analysis of scientific literature
by: Lili Ma, et al.
Published: (2025-02-01)

Risk Assessment of Dyslipidemias, Hyperglycemia, Hyperuricemia, and Hypertension Utilizing Self-Reported Body Silhouettes
by: Ruben Blachman-Braun, et al.
Published: (2023-01-01)

Association of LDL‐C/HDL‐C Ratio With Hyperuricemia: A National Cohort Study
by: Yanyu Zhang, et al.
Published: (2025-01-01)

Nonlinear association between proteinuria levels and the risk of cardiovascular disease events and all-cause mortality among chronic kidney disease patients
by: Haiying Song, et al.
Published: (2024-12-01)

The effects of diacylglycerol edible oil intervention in patients with chronic metabolic syndrome combined with asymptomatic hyperuricemia: study protocol for a multicenter, prospective, double-blind, randomized controlled trial
by: Gui-yu Li, et al.
Published: (2025-01-01)